Operation Cure.All Goes After Swiss Company

Operation Cure.All Goes After Swiss Company

WASHINGTON--The Federal Trade Commission, as partof Operation Cure.All, charged the Switzerland-based Dr. Clark BehandlungzentrumGMbH with making numerous unsubstantiated efficacy claims for a variety ofdietary supplements and devices sold on the Internet. The complaint also namedDr. Clark Research Association (DRCA), a California corporation that uses a SanDiego address, and the companies' owner, David P. Amrein. The complaint wasfiled in the U.S. District Court for the Northern District of Ohio on Jan. 8.

The products in question include Super-Zapper Deluxe, a devicethat purportedly kills disease-causing parasites via electricity; theSyncrometer, a device that is promoted to diagnose disease; and Dr. Clark's New21 Day Program for Advanced Cancers, which included dietary supplements and,when co-administered with the Zapper, allegedly renders surgery and chemotherapyunnecessary.

According to the defendants' Web sites, www.drclark.netand www.drclark.com, "Electricity cannow be used ... to kill bacteria, viruses and parasites in minutes." And,when discussing the 21 Day Program, the sites note, "We have seen amazingresults in hopeless cases with this program that are nothing short ofmiraculous."

FTC charged the defendants did not have a reasonable basis tosubstantiate the claims made in their advertisements.